共 50 条
- [1] Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial[J]. LANCET INFECTIOUS DISEASES, 2014, 14 (04): : 281 - 290Grinsztejn, BeatrizHosseinipour, Mina C.Ribaudo, Heather J.Swindells, SusanEron, JosephChen, Ying Q.Wang, LeiOu, San-SanAnderson, MaijaMcCauley, MarybethGamble, TheresaKumarasamy, NagalingeshwaranHakim, James G.Kumwenda, JohnstonePilotto, Jose H. S.Godbole, Sheela V.Chariyalertsak, Suwatde Melo, Marineide GoncalvesMayer, Kenneth H.Eshleman, Susan H.Piwowar-Manning, EstelleMakhema, JosephMills, Lisa A.Panchia, RavindreSanne, IanGallant, JoelHoffman, IrvingTaha, Taha E.Nielsen-Saines, KarinCelentano, DavidEssex, MaxHavlir, DianeCohen, Myron S.
- [2] Effect of early versus delayed initiation of antiretroviral therapy (ART) on clinical outcomes in the HPTN 052 randomized clinical trial[J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 60 - 61Grinsztejn, B.Hosseinipour, M.Swindells, S.Ribaudo, H.Eron, J.Chen, Y. Q.Wang, L.Ou, S. -S.Anderson, M.McCauley, M.Gamble, T.Kumarasamy, N.Hakim, J.Kumwenda, J.Pilotto, J.Godbole, S.Chariyalertsak, S.Santos, B.Mayer, K.Eshleman, S.Piwowar-Manning, E.Cottle, L.Makhema, J.Mills, L.Panchia, R.Sanne, I.Elharrar, V.Havlir, D.Cohen, M. S.
- [3] Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial (vol 399, pg 1779, 2022)[J]. LANCET, 2022, 399 (10337): : 1778 - 1778Delany-Moretlwe, S.Hughes, J. P.Bock, P.
- [4] Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial[J]. LANCET, 2022, 399 (10337): : 1779 - 1789Delany-Moretlwe, SineadHughes, James P.Bock, PeterOuma, Samuel GurrionHunidzarira, PortiaKalonji, DishikiKayange, NoelMakhema, JosephMandima, PatriciaMathew, CarrieSpooner, ElizabethMpendo, JulietMukwekwerere, PamelaMgodi, NyaradzoNtege, Patricia NahiryaNair, GonasagrieNakabiito, ClemensiaNuwagaba-Biribonwoha, HarrietPanchia, RavindreSingh, NishantaSiziba, BekezelaFarrior, JenniferRose, ScottAnderson, Peter L.Eshleman, Susan H.Marzinke, Mark A.Hendrix, Craig W.Beigel-Orme, StephanieHosek, SybilTolley, ElizabethSista, NirupamaAdeyeye, AdeolaRooney, James F.Rinehart, AlexSpreen, William R.Smith, KimberlyHanscom, BrettCohen, Myron S.Hosseinipour, Mina C.
- [5] Adherence to Early Antiretroviral Therapy: Results From HPTN 052, a Phase III, Multinational Randomized Trial of ART to Prevent HIV-1 Sexual Transmission in Serodiscordant Couples[J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 69 (02) : 234 - 240Safren, Steven A.Mayer, Kenneth H.Ou, San-SanMcCauley, MarybethGrinsztejn, BeatrizHosseinipour, Mina C.Kumarasamy, NagalingeswaranGamble, TheresaHoffman, IrvingCelentano, DavidChen, Ying QingCohen, Myron S.
- [6] Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial (vol 14, pg 563, 2014)[J]. LANCET INFECTIOUS DISEASES, 2014, 14 (09): : 793 - 793Mfinanga, S. G.Kirenga, B. J.Chanda, D. M.
- [7] Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection (vol 20, pg 1789, 2006)[J]. AIDS, 2006, 20 (13) : 1789 - 1789Chiappini, ElenaGalli, LuisaTovo, Pier-AngeloGabiano, ClaraGattinara, Guido CatelliGuarino, AlfredoBadolato, RaffaeleGiaquinto, CarloLisi, Catiusciade Martino, Maurizio
- [8] Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial[J]. LANCET INFECTIOUS DISEASES, 2022, 22 (12): : 1676 - 1676Gunst, Jesper D.Pahus, Marie H.Rosas-Umbert, MiriamLu, I-NaBenfield, ThomasNielsen, HenrikJohansen, Isik S.Mohey, RajeshOstergaard, LarsKlastrup, VibekeKhan, MaryamSchleimann, Mariane H.Olesen, RikkeStovring, HenrikDenton, Paul W.Kinloch, Natalie N.Copertino, Dennis C.Ward, Adam R.Alberto, Winiffer D. ConceNielsen, Silke D.Puertas, Maria C.Ramos, VictorReeves, Jacqueline D.Petropoulos, Christos J.Martinez-Picado, JavierBrumme, Zabrina L.Jones, R. BradFox, JulieTolstrup, MartinNussenzweig, Michel C.Caskey, MarinaFidler, SarahSogaard, Ole S.
- [9] Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial[J]. Nature Medicine, 2022, 28 : 2424 - 2435Jesper D. GunstMarie H. PahusMiriam Rosás-UmbertI-Na LuThomas BenfieldHenrik NielsenIsik S. JohansenRajesh MoheyLars ØstergaardVibeke KlastrupMaryam KhanMariane H. SchleimannRikke OlesenHenrik StøvringPaul W. DentonNatalie N. KinlochDennis C. CopertinoAdam R. WardWiniffer D. Conce AlbertoSilke D. NielsenMaria C. PuertasVictor RamosJacqueline D. ReevesChristos J. PetropoulosJavier Martinez-PicadoZabrina L. BrummeR. Brad JonesJulie FoxMartin TolstrupMichel C. NussenzweigMarina CaskeySarah FidlerOle S. Søgaard
- [10] Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial[J]. NATURE MEDICINE, 2022, 28 (11) : 2424 - +Gunst, Jesper D.Pahus, Marie H.Rosas-Umbert, MiriamLu, I-NaBenfield, ThomasNielsen, HenrikJohansen, Isik S.Mohey, RajeshOstergaard, LarsKlastrup, VibekeKhan, MaryamSchleimann, Mariane H.Olesen, RikkeStovring, HenrikDenton, Paul W.Kinloch, Natalie N.Copertino, Dennis C.Ward, Adam R.Alberto, Winiffer D. ConceNielsen, Silke D.Puertas, Maria C.Ramos, VictorReeves, Jacqueline D.Petropoulos, Christos J.Martinez-Picado, JavierBrumme, Zabrina L.Jones, R. BradFox, JulieTolstrup, MartinNussenzweig, Michel C.Caskey, MarinaFidler, SarahSogaard, Ole S.